Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

January 31, 2017

Study Completion Date

January 16, 2018

Conditions
Lung Cancer
Interventions
DRUG

carboplatin

IV

DRUG

paclitaxel

IV

RADIATION

radiation therapy

Defined per the protocol

Trial Locations (11)

13210

State University of New York Upstate Medical University, Syracuse

21201

University of Maryland/Greenebaum Cancer Center, Baltimore

60637

University of Chicago, Chicago

85054

Mayo Clinic Hospital, Phoenix

85259

Mayo Clinic Scottsdale, Scottsdale

92093-0987

Moores University of California San Diego Cancer Center, La Jolla

02215

Dana Farber Cancer Institute, Boston

27599-7305

University of North Carolina - Chapel Hill, Chapel Hill

27157-1030

Wake Forest University Health Sciences, Winston-Salem

02903

Rhode Island Hospital, Providence

05401

University of Vermont, Burlington

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT01486602 - Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | Biotech Hunter | Biotech Hunter